Butterfly Network, Inc. (Nasdaq: BFLY) is a medical technology company specializing in handheld, whole-body ultrasound devices built on its proprietary Ultrasound-on-Chip semiconductor platform, enabling point-of-care imaging via connected smartphones and tablets. BFLY entered public markets in February 2021 through its de-SPAC merger with Longboard Acquisition Corp., a blank-check vehicle that completed its IPO in 2020 targeting the healthcare technology sector. As a fully reporting public company, BFLY filed an 8-K current report with the SEC on May 8, 2026, under accession number 0001804176-26-000019, disclosing material developments in accordance with its ongoing regulatory obligations. Sign up on SpacDesk for full filing data, SPAC deal analytics, and real-time tracking across BFLY and thousands of other vehicles.